Depletion of TDP-43 decreases fibril and plaque β-amyloid and exacerbates neurodegeneration in an Alzheimer’s mouse model

Katherine D. LaClair, Aneesh Donde, Jonathan P. Ling, Yun Ha Jeong, Resham Chhabra, Lee J Martin, Philip Chun Wong

Research output: Contribution to journalArticle

Abstract

TDP-43 proteinopathy, initially associated with ALS and FTD, is also found in 30–60% of Alzheimer’s disease (AD) cases and correlates with worsened cognition and neurodegeneration. A major component of this proteinopathy is depletion of this RNA-binding protein from the nucleus, which compromises repression of non-conserved cryptic exons in neurodegenerative diseases. To test whether nuclear depletion of TDP-43 may contribute to the pathogenesis of AD cases with TDP-43 proteinopathy, we examined the impact of depletion of TDP-43 in populations of neurons vulnerable in AD, and on neurodegeneration in an AD-linked context. Here, we show that some populations of pyramidal neurons that are selectively vulnerable in AD are also vulnerable to TDP-43 depletion in mice, while other forebrain neurons appear spared. Moreover, TDP-43 depletion in forebrain neurons of an AD mouse model exacerbates neurodegeneration, and correlates with increased prefibrillar oligomeric Aβ and decreased Aβ plaque burden. These findings support a role for nuclear depletion of TDP-43 in the pathogenesis of AD and provide strong rationale for developing novel therapeutics to alleviate the depletion of TDP-43 and functional antemortem biomarkers associated with its nuclear loss.

Original languageEnglish (US)
Pages (from-to)859-873
Number of pages15
JournalActa Neuropathologica
Volume132
Issue number6
DOIs
StatePublished - Dec 1 2016

Fingerprint

Amyloid Plaques
Amyloid
Alzheimer Disease
TDP-43 Proteinopathies
Prosencephalon
Neurons
RNA-Binding Proteins
Pyramidal Cells
Vulnerable Populations
Neurodegenerative Diseases
Cognition
Exons
Biomarkers
Population

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Depletion of TDP-43 decreases fibril and plaque β-amyloid and exacerbates neurodegeneration in an Alzheimer’s mouse model. / LaClair, Katherine D.; Donde, Aneesh; Ling, Jonathan P.; Jeong, Yun Ha; Chhabra, Resham; Martin, Lee J; Wong, Philip Chun.

In: Acta Neuropathologica, Vol. 132, No. 6, 01.12.2016, p. 859-873.

Research output: Contribution to journalArticle

LaClair, Katherine D. ; Donde, Aneesh ; Ling, Jonathan P. ; Jeong, Yun Ha ; Chhabra, Resham ; Martin, Lee J ; Wong, Philip Chun. / Depletion of TDP-43 decreases fibril and plaque β-amyloid and exacerbates neurodegeneration in an Alzheimer’s mouse model. In: Acta Neuropathologica. 2016 ; Vol. 132, No. 6. pp. 859-873.
@article{4f395a4d555a43f4a3946a070de49cea,
title = "Depletion of TDP-43 decreases fibril and plaque β-amyloid and exacerbates neurodegeneration in an Alzheimer’s mouse model",
abstract = "TDP-43 proteinopathy, initially associated with ALS and FTD, is also found in 30–60{\%} of Alzheimer’s disease (AD) cases and correlates with worsened cognition and neurodegeneration. A major component of this proteinopathy is depletion of this RNA-binding protein from the nucleus, which compromises repression of non-conserved cryptic exons in neurodegenerative diseases. To test whether nuclear depletion of TDP-43 may contribute to the pathogenesis of AD cases with TDP-43 proteinopathy, we examined the impact of depletion of TDP-43 in populations of neurons vulnerable in AD, and on neurodegeneration in an AD-linked context. Here, we show that some populations of pyramidal neurons that are selectively vulnerable in AD are also vulnerable to TDP-43 depletion in mice, while other forebrain neurons appear spared. Moreover, TDP-43 depletion in forebrain neurons of an AD mouse model exacerbates neurodegeneration, and correlates with increased prefibrillar oligomeric Aβ and decreased Aβ plaque burden. These findings support a role for nuclear depletion of TDP-43 in the pathogenesis of AD and provide strong rationale for developing novel therapeutics to alleviate the depletion of TDP-43 and functional antemortem biomarkers associated with its nuclear loss.",
author = "LaClair, {Katherine D.} and Aneesh Donde and Ling, {Jonathan P.} and Jeong, {Yun Ha} and Resham Chhabra and Martin, {Lee J} and Wong, {Philip Chun}",
year = "2016",
month = "12",
day = "1",
doi = "10.1007/s00401-016-1637-y",
language = "English (US)",
volume = "132",
pages = "859--873",
journal = "Acta Neuropathologica",
issn = "0001-6322",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Depletion of TDP-43 decreases fibril and plaque β-amyloid and exacerbates neurodegeneration in an Alzheimer’s mouse model

AU - LaClair, Katherine D.

AU - Donde, Aneesh

AU - Ling, Jonathan P.

AU - Jeong, Yun Ha

AU - Chhabra, Resham

AU - Martin, Lee J

AU - Wong, Philip Chun

PY - 2016/12/1

Y1 - 2016/12/1

N2 - TDP-43 proteinopathy, initially associated with ALS and FTD, is also found in 30–60% of Alzheimer’s disease (AD) cases and correlates with worsened cognition and neurodegeneration. A major component of this proteinopathy is depletion of this RNA-binding protein from the nucleus, which compromises repression of non-conserved cryptic exons in neurodegenerative diseases. To test whether nuclear depletion of TDP-43 may contribute to the pathogenesis of AD cases with TDP-43 proteinopathy, we examined the impact of depletion of TDP-43 in populations of neurons vulnerable in AD, and on neurodegeneration in an AD-linked context. Here, we show that some populations of pyramidal neurons that are selectively vulnerable in AD are also vulnerable to TDP-43 depletion in mice, while other forebrain neurons appear spared. Moreover, TDP-43 depletion in forebrain neurons of an AD mouse model exacerbates neurodegeneration, and correlates with increased prefibrillar oligomeric Aβ and decreased Aβ plaque burden. These findings support a role for nuclear depletion of TDP-43 in the pathogenesis of AD and provide strong rationale for developing novel therapeutics to alleviate the depletion of TDP-43 and functional antemortem biomarkers associated with its nuclear loss.

AB - TDP-43 proteinopathy, initially associated with ALS and FTD, is also found in 30–60% of Alzheimer’s disease (AD) cases and correlates with worsened cognition and neurodegeneration. A major component of this proteinopathy is depletion of this RNA-binding protein from the nucleus, which compromises repression of non-conserved cryptic exons in neurodegenerative diseases. To test whether nuclear depletion of TDP-43 may contribute to the pathogenesis of AD cases with TDP-43 proteinopathy, we examined the impact of depletion of TDP-43 in populations of neurons vulnerable in AD, and on neurodegeneration in an AD-linked context. Here, we show that some populations of pyramidal neurons that are selectively vulnerable in AD are also vulnerable to TDP-43 depletion in mice, while other forebrain neurons appear spared. Moreover, TDP-43 depletion in forebrain neurons of an AD mouse model exacerbates neurodegeneration, and correlates with increased prefibrillar oligomeric Aβ and decreased Aβ plaque burden. These findings support a role for nuclear depletion of TDP-43 in the pathogenesis of AD and provide strong rationale for developing novel therapeutics to alleviate the depletion of TDP-43 and functional antemortem biomarkers associated with its nuclear loss.

UR - http://www.scopus.com/inward/record.url?scp=84992346874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992346874&partnerID=8YFLogxK

U2 - 10.1007/s00401-016-1637-y

DO - 10.1007/s00401-016-1637-y

M3 - Article

C2 - 27785573

AN - SCOPUS:84992346874

VL - 132

SP - 859

EP - 873

JO - Acta Neuropathologica

JF - Acta Neuropathologica

SN - 0001-6322

IS - 6

ER -